Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -253.57% is 24% below its 5-year average of -204.11%, around the middle of its 5-year range (-352.57%–-109.03%).
As of the fiscal period ended Tuesday, June 30, 2026. 1.34% below its 12-month average of -250.21%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q1 FY2027 (2026-06-30): -253.57%.
RETURN ON INVESTED CAPITAL (ROIC)
-253.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-250.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-212.25%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-204.11%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-149.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-1.34%
CURRENT VS 3Y AVG
-19.47%
CURRENT VS 5Y AVG
-24.23%
CURRENT VS 10Y AVG
-69.35%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.10%
median of 759 covered companies
CURRENT VS SECTOR MEDIAN
-643.60%
vs the sector median at left
Modular Medical, Inc.
Market Cap
$21.76M
Return on Invested Capital (ROIC)
-253.57%
TTM Avg
-250.21%
3Y Avg
-212.25%
5Y Avg
-204.11%
Market Cap
$22.11M
Return on Invested Capital (ROIC)
-14.21%
TTM Avg
-12.54%
3Y Avg
-12.42%
5Y Avg
-37.50%
Market Cap
$22.36M
Return on Invested Capital (ROIC)
-248.21%
TTM Avg
-225.06%
3Y Avg
-147.38%
5Y Avg
-102.77%
Market Cap
$20.99M
Return on Invested Capital (ROIC)
-27.14%
TTM Avg
-181.80%
3Y Avg
-158.13%
5Y Avg
-129.64%
Market Cap
$22.98M
Return on Invested Capital (ROIC)
-36.89%
TTM Avg
-112.27%
3Y Avg
-56.18%
5Y Avg
-37.49%
Market Cap
$20.01M
Return on Invested Capital (ROIC)
-1489.99%
TTM Avg
-2573.36%
3Y Avg
-1757.31%
5Y Avg
-1757.31%
Market Cap
$19.67M
Return on Invested Capital (ROIC)
-51.68%
TTM Avg
-130.81%
3Y Avg
-134.17%
5Y Avg
-120.84%
Market Cap
$19.53M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-171.06%
3Y Avg
-106.73%
5Y Avg
-106.73%
Market Cap
$24.09M
Return on Invested Capital (ROIC)
-78.16%
TTM Avg
-118.00%
3Y Avg
-120.55%
5Y Avg
-93.95%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Modular Medical, Inc. (MODD) | $21.76M | -253.57% | -250.21% | -212.25% | -204.11% |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.11M | -14.21% | -12.54% | -12.42% | -37.50% |
| LeonaBio, Inc. (LONA)vs › | $22.36M | -248.21% | -225.06% | -147.38% | -102.77% |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.99M | -27.14% | -181.80% | -158.13% | -129.64% |
| Rein Therapeutics Inc. (RNTX)vs › | $22.98M | -36.89% | -112.27% | -56.18% | -37.49% |
| Actuate Therapeutics Inc (ACTU)vs › | $20.01M | -1489.99% | -2573.36% | -1757.31% | -1757.31% |
| P3 Health Partners Inc. (PIII)vs › | $19.67M | -51.68% | -130.81% | -134.17% | -120.84% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $19.53M | N/A | -171.06% | -106.73% | -106.73% |
| Kyntra Bio, Inc. (KYNB)vs › | $24.09M | -78.16% | -118.00% | -120.55% | -93.95% |
| NextCure, Inc. (NXTC)vs › | $18.95M | -259.91% | -114.62% | -82.11% | -62.05% |
ROIC
-253.6%
ROE
-260.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -253.57% |
| 2026-03-31 | -212.67% |
| 2025-12-31 | -332.36% |
| 2025-09-30 | -273.96% |
| 2025-06-30 | -178.47% |
| 2025-03-31 | -109.03% |
| 2024-12-31 | -170.81% |
| 2024-09-30 | -249.82% |
| 2024-06-30 | -206.16% |
| 2024-03-31 | -141.91% |
| 2023-12-31 | -352.57% |
| 2023-09-30 | -166.21% |
| 2023-06-30 | -111.65% |
| 2023-03-31 | -221.48% |
| 2022-12-31 | -178.64% |
| 2022-09-30 | -137.83% |
| 2022-06-30 | -111.91% |
| 2022-03-31 | -168.15% |
| 2021-06-30 | -300.80% |
| 2021-03-31 | -504.78% |
| 2020-12-31 | -1148.08% |
| 2020-09-30 | -416.28% |
| 2020-06-30 | -186.85% |
| 2020-03-31 | -167.27% |
| 2019-12-31 | -123.44% |
| 2019-09-30 | -89.32% |
| 2019-06-30 | -62.39% |
| 2019-03-31 | -39.81% |
| 2018-12-31 | -24.29% |
| 2018-09-30 | -33.87% |
| 2018-06-30 | -21.56% |
| 2018-03-31 | -16.27% |
| 2017-12-31 | -11.54% |
| 2017-09-30 | -5.49% |
| 2017-06-30 | -7.01% |
| 2017-03-31 | -7.36% |
